Skip to main content

Published locations for Adding pembrolizumab to cisplatin-based CRT shows promise in HPV+ head and neck cancers

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adding pembrolizumab to cisplatin-based CRT shows promise in HPV+ head and neck cancers

User login

  • Reset your password
  • /content/adding-pembrolizumab-cisplatin-based-crt-shows-promise-hpv-head-and-neck-cancers
  • /oncologypractice/article/184301/head-neck-cancers/adding-pembrolizumab-cisplatin-based-crt-shows
  • /hematology-oncology/article/184301/head-neck-cancers/adding-pembrolizumab-cisplatin-based-crt-shows